News
Alumna Toni Rinow Appointed CEO of Pivot Pharmaceuticals
Published: 23 August 2019
Dr. Toni Rinow (MBA ’06) was recently appointed to serve as the next CEO of Pivot Pharmaceuticals, a Vancouver-based biopharmaceutical company specializing in medical cannabis products.
With a doctorate in physical chemistry and 20 years of pharmaceutical industry experience, Dr. Rinow is well-positioned to drive global expansion in key cannabis markets in Canada, the U.S., and the EU.
Feedback
For more information or if you would like to report an error, please web.desautels [at] mcgill.ca (subject: Website%20News%20Comments) (contact us).
